Non-invasive technology for isolating Rare Circulating Cells

ScreenCell® is a simple and innovative non-invasive technology for isolating Circulating Rare Cells (CRCs) from whole blood, and potentially any atypical cell in biological fluids.

By providing an easy access to fixed or live Circulating Tumor Cells (CTCs) and Circulating Tumor Microemboli (CTMs), the ScreenCell devices allow a full range access to phenotypical, genotypical, and functional characterization of these cells. A very small quantity of white blood cells can be retained on the isolation support with CTCs.

The ScreenCell technology also presents advantages for isolation of Circulating Fetal Cells (CFCs) drawn from peripheral blood of pregnant women but ScreenCell devices are for research use only for this matter.